Effect of cholesteryl ester transfer protein (CETP) expression on diet-induced hyperlipidemias in transgenic rats

Atherosclerosis

Volumn 178, Issue 2, 2005, Pages 279-286

  Zak, Zoulika ^a,c   Gautier, Thomas ^a   Dumont, Laure ^a   Masson, David ^a   Deckert, Valérie ^a   Duverneuil, Linda ^a   Pais De Barros, Jean Paul ^a   Le Guern, Naig ^a   Schneider, Martina ^a   Moulin, Philippe ^b   Bataillard, Alain ^c   Lagrost, Laurent ^a  

^a INSERM   (France)

^b Service d'Endocrinologie   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

CETP; Diet; Hypercholesterolemia; Hypertriglyceridemia; Lipoprotein profile; Transgenic rats; VLDL

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE DIET; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; LIPID DIET; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; TRANSGENIC MOUSE; WILD TYPE;

EID: 19944431892     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.10.006     Document Type: Article

References (30)

1. M.L. Brown, A. Inazu, and C.B. Hesler Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins Nature 342 1989 448 451
2. A. Inazu, X.C. Jiang, and T. Haraki Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol J Clin Invest 94 1994 1872 1882
3. G.J. de Grooth, J.A. Kuivenhoven, and A.F. Stalenhoef Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study Circulation 105 2002 2159 2165
4. R.W. Clark, T.A. Sutfin, and R.B. Ruggeri Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib Arterioscler Thromb Vasc Biol 24 2004 1 9
5. C.W. Rittershaus, D.P. Miller, and L.J. Thomas Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis Arterioscler Thromb Vasc Biol 20 2000 2106 2112
6. M. Sugano, N. Makino, and S. Sawada Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits J Biol Chem 273 1998 5033 5036
7. H. Okamoto, F. Yonemori, and K. Wakitani A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits Nature 406 2000 203 207
8. H. Shinkaï Cholesteryl ester transfer protein inhibitors Expert Opin Ther Patents 11 2001 739 745
9. P.J. Barter, H.B. Brewer Jr., and M.J. Chapman Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis Arterioscler Thromb Vasc Biol 23 2003 160 167
10. L. Lagrost Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies Biochim Biophys Acta 1215 1994 209 236
11. Y.C. Ha, and P.J. Barter Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species Comp Biochem Physiol B 71 1982 265 269
12. E. Quinet, A. Tall, R. Ramakrishnan, and L. Rudel Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins J Clin Invest 87 1991 1559 1566
13. Z. Zak, L. Lagrost, and T. Gautier Expression of simian CETP in normolipidemic Fisher rats has a profound effect on large sized apoE-containing HDL J Lipid Res 43 2002 2164 2171
14. R. McPherson, C.J. Mann, and A.R. Tall Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables Arterioscler Thromb 11 1991 797 804
15. V. Guyard-Dangremont, L. Lagrost, P. Gambert, and C. Lallemant Competitive enzyme-linked immunosorbent assay of the human cholesteryl ester transfer protein (CETP) Clin Chim Acta 231 1994 147 160
16. F. Tato, G.L. Vega, A.R. Tall, and S.M. Grundy Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia Arterioscler Thromb Vasc Biol 15 1995 112 120
17. Y. Deshaies Plasma lipoprotein cholesterol and triglycerides and lipoprotein lipase activity in epididymal white adipose tissue of rats fed high sucrose or high corn oil diets Can J Physiol Pharmacol 64 1986 885 891
18. T. Funatsu, M. Goto, and H. Kakuta Reduction in hepatic non-esterified fatty acid concentration after long-term treatment with atorvastatin lowers hepatic triglyceride synthesis and its secretion in sucrose-fed rats Biochim Biophys Acta 1580 2002 161 170
19. S. Yamashita, D.L. Sprecher, and N. Sakai Accumulation of apolipoprotein E-rich high-density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency J Clin Invest 86 1990 688 695
20. T. Arai, T. Tsukada, T. Murase, and K. Matsumoto Particle size analysis of high-density lipoproteins in patients with genetic cholesteryl ester transfer protein deficiency Clin Chim Acta 301 2000 103 117
21. A.S. Plump, L. Masucci-Magoulas, and C. Bruce Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression Arterioscler Thromb Vasc Biol 19 1999 1105 1110
22. L. Masucci-Magoulas, I.J. Goldberg, and C.L. Bisgaier A mouse model with features of familial combined hyperlipidemia Science 275 1997 391 394
23. J.C. Escola-Gil, J. Julve, and A. Marzal-Casacuberta ApoAII expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance J Lipid Res 42 2001 241 248
24. L. Masucci-Magoulas, I.J. Goldberg, and C.L. Bisgaier A mouse model with features of familial combined hyperlipidemia Science 275 1997 391 394
25. X.C. Jiang, L. Masucci-Magoulas, and J. Mar Down-regulation of mRNA for the low-density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. Mechanism to explain accumulation of lipoprotein B particles J Biol Chem 268 1993 27406 27412
26. T. Hayek, L. Masucci-Magoulas, and X. Jiang Decreased early atherosclerosis lesions in hypertriglyceridemic mice expressed cholesteryl ester transfer protein transgene J Clin Invest 96 1995 2071 2074
27. M. Guerin, W. Le Goff, and T.S. Lassel Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes: impact of the degree of triglyceridemia Arterioscler Thromb Vasc Biol 21 2001 282 288
28. C.J. Mann, F.T. Yen, A.M. Grant, and B.E. Bihain Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia J Clin Invest 88 1991 2059 2066
29. J.D. Bagdade, M.C. Ritter, and P.V. Subbaiah Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia J Clin Invest 87 1991 1259 1265
30. P.E. Fielding, C.J. Fielding, R.J. Havel, J.P. Kane, and P. Tun Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma J Clin Invest 71 1983 449 460